We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
Literature
1
1.Praag, HM van. A critical investigation of the importance of monoamine oxidase inhibition as a therapeutic principle in the treatment of depression. Utrecht: Thesis 1962.Google Scholar
2
2.Praag, HM van. (Re)-minding our business. Hum Psychophar-macol1990;5:1–2.CrossRefGoogle Scholar
4.Praag, HM van. ‘Make-believes’ in Psychiatry or the Perils of Progress. Monogr Ser Depart Psychiat Albert Einstein Coll Med Yeshiva Univ. New York: Montefiore Medical Center, 1993.Google Scholar
5
5.Praag, HM van, Korf, J, Puite, J. 5-hydroxyyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature1970;225:1259–60.CrossRefGoogle ScholarPubMed
6
6.Praag, HM van. Socio-biological psychiatry, brain and environment. Compr Psychiat1981;22:441–50.CrossRefGoogle Scholar